主动脉狭窄与视神经病变的相关性:一项基于人群的队列研究

IF 1.8 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
In vivo Pub Date : 2025-07-01 DOI:10.21873/invivo.14009
Chia-Yi Lee, Shun-Fa Yang, Elsa Lin-Chin Mai, Jing-Yang Huang, Chao-Bin Yeh, Chao-Kai Chang
{"title":"主动脉狭窄与视神经病变的相关性:一项基于人群的队列研究","authors":"Chia-Yi Lee, Shun-Fa Yang, Elsa Lin-Chin Mai, Jing-Yang Huang, Chao-Bin Yeh, Chao-Kai Chang","doi":"10.21873/invivo.14009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>To survey the potential correlation between aortic stenosis (AS) and subsequent optic neuropathies of glaucoma and ischemic optic neuropathy.</p><p><strong>Patients and methods: </strong>A retrospective cohort study was conducted with the use of the TriNetX database, a project by the US Collaborative Network which enrolled 68 healthcare institutions. PSM There were 426,980 and 426,980 people divided into the AS and non-AS groups after exclusion. The primary outcomes were the development of glaucoma and ischemic optic neuropathy. Cox proportional hazard regression was used to produce the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of the optic neuropathies between groups.</p><p><strong>Results: </strong>There were 11,717 and 8,676 glaucoma episodes found in the AS and no-AS groups, and there were 566 and 391 ischemic optic neuropathy episodes found in the AS and no-AS groups. The AS group had a significantly higher risk of glaucoma (aHR=1.277, 95% CI=1.242-1.312, <i>p</i><0.001) and ischemic optic neuropathy (aHR=1.362, 95% CI=1.197-1.549, <i>p</i><0.001) compared to the non-AS population. The cumulative probability of glaucoma and ischemic optic neuropathy were significantly higher in the AS group than the non-AS group (both <i>p</i><0.001). In the multivariate analysis, the incidence of ischemic optic neuropathy was significantly higher in the AS group compared to that of the non-AS group with different characteristics except in those with Asian race, aged 20-44 years old, and aged 65-80 years old (all 95% CIs included 1).</p><p><strong>Conclusion: </strong>The existence of AS correlates to higher risk of developing glaucoma and ischemic optic neuropathy.</p>","PeriodicalId":13364,"journal":{"name":"In vivo","volume":"39 4","pages":"2133-2143"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223618/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Correlation Between Aortic Stenosis and the Subsequent Incidence of Optic Neuropathy: A Population-based Cohort Study.\",\"authors\":\"Chia-Yi Lee, Shun-Fa Yang, Elsa Lin-Chin Mai, Jing-Yang Huang, Chao-Bin Yeh, Chao-Kai Chang\",\"doi\":\"10.21873/invivo.14009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background/aim: </strong>To survey the potential correlation between aortic stenosis (AS) and subsequent optic neuropathies of glaucoma and ischemic optic neuropathy.</p><p><strong>Patients and methods: </strong>A retrospective cohort study was conducted with the use of the TriNetX database, a project by the US Collaborative Network which enrolled 68 healthcare institutions. PSM There were 426,980 and 426,980 people divided into the AS and non-AS groups after exclusion. The primary outcomes were the development of glaucoma and ischemic optic neuropathy. Cox proportional hazard regression was used to produce the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of the optic neuropathies between groups.</p><p><strong>Results: </strong>There were 11,717 and 8,676 glaucoma episodes found in the AS and no-AS groups, and there were 566 and 391 ischemic optic neuropathy episodes found in the AS and no-AS groups. The AS group had a significantly higher risk of glaucoma (aHR=1.277, 95% CI=1.242-1.312, <i>p</i><0.001) and ischemic optic neuropathy (aHR=1.362, 95% CI=1.197-1.549, <i>p</i><0.001) compared to the non-AS population. The cumulative probability of glaucoma and ischemic optic neuropathy were significantly higher in the AS group than the non-AS group (both <i>p</i><0.001). In the multivariate analysis, the incidence of ischemic optic neuropathy was significantly higher in the AS group compared to that of the non-AS group with different characteristics except in those with Asian race, aged 20-44 years old, and aged 65-80 years old (all 95% CIs included 1).</p><p><strong>Conclusion: </strong>The existence of AS correlates to higher risk of developing glaucoma and ischemic optic neuropathy.</p>\",\"PeriodicalId\":13364,\"journal\":{\"name\":\"In vivo\",\"volume\":\"39 4\",\"pages\":\"2133-2143\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12223618/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"In vivo\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21873/invivo.14009\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"In vivo","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21873/invivo.14009","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:探讨青光眼和缺血性视神经病变与主动脉瓣狭窄(AS)的潜在相关性。患者和方法:使用TriNetX数据库进行了一项回顾性队列研究,该数据库是美国协作网络的一个项目,招募了68家医疗机构。排除后分为AS组和non-AS组分别有426,980和426,980人。主要结局是青光眼和缺血性视神经病变的发展。采用Cox比例风险回归计算各组间视神经病变的校正风险比(aHR)和95%可信区间(CI)。结果:AS组和非AS组青光眼发生率分别为11717例和8676例,缺血性视神经病变发生率分别为566例和391例。AS组青光眼发生风险显著增高(aHR=1.277, 95% CI=1.242 ~ 1.312, ppp)。结论:AS的存在与青光眼及缺血性视神经病变发生风险增高相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Correlation Between Aortic Stenosis and the Subsequent Incidence of Optic Neuropathy: A Population-based Cohort Study.

Background/aim: To survey the potential correlation between aortic stenosis (AS) and subsequent optic neuropathies of glaucoma and ischemic optic neuropathy.

Patients and methods: A retrospective cohort study was conducted with the use of the TriNetX database, a project by the US Collaborative Network which enrolled 68 healthcare institutions. PSM There were 426,980 and 426,980 people divided into the AS and non-AS groups after exclusion. The primary outcomes were the development of glaucoma and ischemic optic neuropathy. Cox proportional hazard regression was used to produce the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of the optic neuropathies between groups.

Results: There were 11,717 and 8,676 glaucoma episodes found in the AS and no-AS groups, and there were 566 and 391 ischemic optic neuropathy episodes found in the AS and no-AS groups. The AS group had a significantly higher risk of glaucoma (aHR=1.277, 95% CI=1.242-1.312, p<0.001) and ischemic optic neuropathy (aHR=1.362, 95% CI=1.197-1.549, p<0.001) compared to the non-AS population. The cumulative probability of glaucoma and ischemic optic neuropathy were significantly higher in the AS group than the non-AS group (both p<0.001). In the multivariate analysis, the incidence of ischemic optic neuropathy was significantly higher in the AS group compared to that of the non-AS group with different characteristics except in those with Asian race, aged 20-44 years old, and aged 65-80 years old (all 95% CIs included 1).

Conclusion: The existence of AS correlates to higher risk of developing glaucoma and ischemic optic neuropathy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
In vivo
In vivo 医学-医学:研究与实验
CiteScore
4.20
自引率
4.30%
发文量
330
审稿时长
3-8 weeks
期刊介绍: IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management. The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信